Literature DB >> 21997719

Osteoblastic healing response: discordant PET/CT findings.

Filip Gemmel1, Silvia A Eshuis, Femke van Vollenhoven, Paul Gemmel.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21997719     DOI： 10.1007/s00259-011-1953-3

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  3 in total

1.  Osteoblastic bone lesions developing during treatment with erlotinib indicate major response in patients with non-small cell lung cancer: a brief report.

Authors:  Joline S W Lind; Pieter E Postmus; Egbert F Smit
Journal:  J Thorac Oncol       Date:  2010-04       Impact factor: 15.609

2.  Osteoblastic reaction in non-small cell lung carcinoma and its association to epidermal growth factor receptor tyrosine kinase inhibitors response and prolonged survival.

Authors:  Emilie Pluquet; Jacques Cadranel; Anne Legendre; Michelle Beau Faller; Pierre Jean Souquet; Gerard Zalcman; Maurice Perol; Gislaine Fraboulet; Gerard Oliveiro; Florence De Fraipont; Elisabeth Quoix; Sylvie Lantuejoul; Bernard Milleron; Denis Moro-Sibilot
Journal:  J Thorac Oncol       Date:  2010-04       Impact factor: 15.609

3.  Osteoblastic response as a healing reaction to chemotherapy mimicking progressive disease in patients with small cell lung cancer.

Authors:  Joerg Stattaus; Steffen Hahn; Thomas Gauler; Wilfried Eberhardt; Stefan P Mueller; Michael Forsting; Susanne C Ladd
Journal:  Eur Radiol       Date:  2008-08-02       Impact factor: 5.315
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.